vir combination

Generic: adenoviren nosode, cytomegalovirus nosode, herpes simplex virus 1 dna, herpes simplex virus 2 dna, epstein-barr virus nosode, hepatitis b nosode, herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, influenzinum (2023-2024)

Labeler: deseret biologicals, inc.
NDC Directory HUMAN OTC DRUG UNAPPROVED HOMEOPATHIC Inactive Finished

Drug Facts

Product Profile

Brand Name vir combination
Generic Name adenoviren nosode, cytomegalovirus nosode, herpes simplex virus 1 dna, herpes simplex virus 2 dna, epstein-barr virus nosode, hepatitis b nosode, herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, influenzinum (2023-2024)
Labeler deseret biologicals, inc.
Dosage Form LIQUID
Routes
ORAL
Active Ingredients

hepatitis b virus 33 [hp_X]/mL, herring sperm dna 12 [hp_X]/mL, human adenovirus e serotype 4 strain cl-68578 antigen 12 [hp_C]/mL, human herpesvirus 1 15 [hp_X]/mL, human herpesvirus 2 15 [hp_X]/mL, human herpesvirus 4 16 [hp_C]/mL, human herpesvirus 5 18 [hp_X]/mL, human herpesvirus 6 15 [hp_X]/mL, influenza a virus a/darwin/6/2021 (h3n2) whole 12 [hp_C]/mL, influenza a virus whole 12 [hp_C]/mL, influenza b virus b/austria/1359417/2021 bvr-26 whole 12 [hp_C]/mL, influenza b virus b/phuket/3073/2013 bvr-1b whole 12 [hp_C]/mL

Manufacturer
Deseret Biologicals, Inc.

Identifiers & Regulatory

Product NDC 43742-2193
Product ID 43742-2193_282b98e7-4c85-44bb-b554-b242555987e2
Product Type HUMAN OTC DRUG
Marketing Category UNAPPROVED HOMEOPATHIC
Marketing Start 2024-08-26
Marketing End 2030-02-12

Pharmacologic Class

Classes
actively acquired immunity [pe] live human adenovirus type 4 vaccine [epc] vaccines adenovirus [chemical/ingredient] live unattenuated [chemical/ingredient]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 437422193
Hyphenated Format 43742-2193

Supplemental Identifiers

UPC
0810151884202
UNII
77H9EM77P7 51FI676N6F FKD3DUK39I 22G38P19RL 74J6DNH49U 2A26YW7PNX 7COI029E6K 4IX4VP35CR PMY5J4Z7LS R9HH0NDE2E CYK5P89K8X PS2DCE2WVF

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name vir combination (source: ndc)
Generic Name adenoviren nosode, cytomegalovirus nosode, herpes simplex virus 1 dna, herpes simplex virus 2 dna, epstein-barr virus nosode, hepatitis b nosode, herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, influenzinum (2023-2024) (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 33 [hp_X]/mL
  • 12 [hp_X]/mL
  • 12 [hp_C]/mL
  • 15 [hp_X]/mL
  • 16 [hp_C]/mL
  • 18 [hp_X]/mL
source: ndc
Packaging
  • 30 mL in 1 BOTTLE, DROPPER (43742-2193-1)
source: ndc

Packages (1)

Ingredients (12)

hepatitis b virus (33 [hp_X]/mL) herring sperm dna (12 [hp_X]/mL) human adenovirus e serotype 4 strain cl-68578 antigen (12 [hp_C]/mL) human herpesvirus 1 (15 [hp_X]/mL) human herpesvirus 2 (15 [hp_X]/mL) human herpesvirus 4 (16 [hp_C]/mL) human herpesvirus 5 (18 [hp_X]/mL) human herpesvirus 6 (15 [hp_X]/mL) influenza a virus a/darwin/6/2021 (h3n2) whole (12 [hp_C]/mL) influenza a virus whole (12 [hp_C]/mL) influenza b virus b/austria/1359417/2021 bvr-26 whole (12 [hp_C]/mL) influenza b virus b/phuket/3073/2013 bvr-1b whole (12 [hp_C]/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "282b98e7-4c85-44bb-b554-b242555987e2", "openfda": {"upc": ["0810151884202"], "unii": ["77H9EM77P7", "51FI676N6F", "FKD3DUK39I", "22G38P19RL", "74J6DNH49U", "2A26YW7PNX", "7COI029E6K", "4IX4VP35CR", "PMY5J4Z7LS", "R9HH0NDE2E", "CYK5P89K8X", "PS2DCE2WVF"], "spl_set_id": ["dcc97028-0bd4-45d4-8635-5d4ca9114f06"], "manufacturer_name": ["Deseret Biologicals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 mL in 1 BOTTLE, DROPPER (43742-2193-1)", "package_ndc": "43742-2193-1", "marketing_end_date": "20300212", "marketing_start_date": "20240826"}], "brand_name": "Vir Combination", "product_id": "43742-2193_282b98e7-4c85-44bb-b554-b242555987e2", "dosage_form": "LIQUID", "pharm_class": ["Actively Acquired Immunity [PE]", "Live Human Adenovirus Type 4 Vaccine [EPC]", "Vaccines", "Adenovirus [Chemical/Ingredient]", "Vaccines", "Live", "Unattenuated [Chemical/Ingredient]"], "product_ndc": "43742-2193", "generic_name": "Adenoviren Nosode, Cytomegalovirus Nosode, Herpes Simplex Virus 1 DNA, Herpes Simplex Virus 2 DNA, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Influenzinum (2023-2024)", "labeler_name": "Deseret Biologicals, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Vir Combination", "active_ingredients": [{"name": "HEPATITIS B VIRUS", "strength": "33 [hp_X]/mL"}, {"name": "HERRING SPERM DNA", "strength": "12 [hp_X]/mL"}, {"name": "HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN", "strength": "12 [hp_C]/mL"}, {"name": "HUMAN HERPESVIRUS 1", "strength": "15 [hp_X]/mL"}, {"name": "HUMAN HERPESVIRUS 2", "strength": "15 [hp_X]/mL"}, {"name": "HUMAN HERPESVIRUS 4", "strength": "16 [hp_C]/mL"}, {"name": "HUMAN HERPESVIRUS 5", "strength": "18 [hp_X]/mL"}, {"name": "HUMAN HERPESVIRUS 6", "strength": "15 [hp_X]/mL"}, {"name": "INFLUENZA A VIRUS A/DARWIN/6/2021 (H3N2) WHOLE", "strength": "12 [hp_C]/mL"}, {"name": "INFLUENZA A VIRUS WHOLE", "strength": "12 [hp_C]/mL"}, {"name": "INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE", "strength": "12 [hp_C]/mL"}, {"name": "INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE", "strength": "12 [hp_C]/mL"}], "marketing_category": "UNAPPROVED HOMEOPATHIC", "marketing_end_date": "20300212", "marketing_start_date": "20240826"}